|
Market Cap (21-Jun) $15,071,113 (1,218th) |
Close (30-Jun) $6.60 |
Volume (30-Jun) 0 |
Shortsold (31-Aug) 59,797 (0.02%) (544th) |
|
52w High $0.000 |
52w Low $0.000 |
P/E - |
EPS -547.5 |
MDC released this announcement to the ASX on 20 May 2021, 11:26. The announcement is marked as price sensitive, and is 2 page(s) in length and 169.38kb in size.
You can view all announcements from MDC and see how they appear on a price chart on the announcements page.
At the date of this announcement, MDC was 0.017% short sold according to ASIC data. It was ranked the 547th most shorted stock on the ASX. It is now ranked as the 544th most shorted stock on the ASX with 0.017% of total shares short sold as of the latest reported data (31 August 2021).
| Other Recent Announcements from MDC | |
|---|---|
| Medlab Update to Shareholders | 7 June 2023, 10:22 |
| Response to ASX Query | 23 March 2023, 15:45 |
| Medlab Update to Shareholders | 21 March 2023, 10:39 |
| Synthetic formulation in pending global PIII Trial | 20 May 2021, 11:26 |
| Medlab Presenting at Jefferies Global Healthcare Conference | 13 May 2021, 14:04 |
| Appointment of CFO & Company Secretary | 13 May 2021, 12:20 |
| Notice under Section 708A(5)(e) of the Corporations Act | 5 May 2021, 13:31 |
You must be logged in to post a reply.
Medlab Clinical 